[go: up one dir, main page]

AU1681799A - Percutaneously absorbable levodopa-containing preparation - Google Patents

Percutaneously absorbable levodopa-containing preparation

Info

Publication number
AU1681799A
AU1681799A AU16817/99A AU1681799A AU1681799A AU 1681799 A AU1681799 A AU 1681799A AU 16817/99 A AU16817/99 A AU 16817/99A AU 1681799 A AU1681799 A AU 1681799A AU 1681799 A AU1681799 A AU 1681799A
Authority
AU
Australia
Prior art keywords
levodopa
containing preparation
percutaneously absorbable
percutaneously
absorbable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16817/99A
Inventor
Masaru Hamabe
Takayuki Oka
Hiroko Udagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sekisui Chemical Co Ltd
Original Assignee
Sekisui Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Chemical Co Ltd filed Critical Sekisui Chemical Co Ltd
Publication of AU1681799A publication Critical patent/AU1681799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU16817/99A 1997-12-17 1998-12-16 Percutaneously absorbable levodopa-containing preparation Abandoned AU1681799A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP9-347994 1997-12-17
JP34799497 1997-12-17
JP23418298 1998-08-20
JP10-234182 1998-08-20
PCT/JP1998/005670 WO1999030702A1 (en) 1997-12-17 1998-12-16 Percutaneously absorbable levodopa-containing preparation

Publications (1)

Publication Number Publication Date
AU1681799A true AU1681799A (en) 1999-07-05

Family

ID=26531412

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16817/99A Abandoned AU1681799A (en) 1997-12-17 1998-12-16 Percutaneously absorbable levodopa-containing preparation

Country Status (2)

Country Link
AU (1) AU1681799A (en)
WO (1) WO1999030702A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6746688B1 (en) 1996-10-13 2004-06-08 Neuroderm Ltd. Apparatus for the transdermal treatment of Parkinson's disease
JPWO2019171843A1 (en) * 2018-03-05 2021-02-25 パナソニックＩｐマネジメント株式会社 Cosmetics or medical materials

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
IL119417A (en) * 1996-10-13 2003-02-12 Moshe Kushnir Pharmaceutical composition for transdermal administration of levodopa for parkinson's disease

Also Published As

Publication number Publication date
WO1999030702A1 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
AU692944B2 (en) Percutaneously absorbable patch
AU1281895A (en) Percutaneously absorbable preparation
EP0882553B8 (en) Knife
AU8687898A (en) Suture retrograder
AU4594197A (en) Suture cutter
AUPO152596A0 (en) Roofbolter
AU5865694A (en) Novel, percutaneously absorbable preparation
AU9314298A (en) Anchor
AU5335798A (en) Stomatic composition
AU8747498A (en) Food-preservative composition
AU692924B2 (en) Percutaneously absorbable preparation
EP0719561A4 (en) Percutaneously absorbable preparation
AU9066598A (en) Substituted 4-benzoyl-pyrazoles
AU8121998A (en) Composition
AU6006898A (en) Skin preparation
AU7830498A (en) Instant yogurt preparation
AU5516599A (en) Substituted 3-aryl-pyrazoles
AU1098499A (en) Emulsifier-lipid composition
AU1688099A (en) Pharmaceutical preparation
AU6090898A (en) Substituted 4-benzoyl-pyrazoles
AU4507899A (en) Substituted n-aryl-o-alkyl-carbamates
AU4031897A (en) Stanozolol-containing percutaneously absorbable preparation
AU1681799A (en) Percutaneously absorbable levodopa-containing preparation
AU2279800A (en) Pharmaceutical preparation
AU1649700A (en) Novel formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase